E. Anderson Et Al. , "CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS," 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , no.60, Geneve, Switzerland, pp.112, 2021
Anderson, E. Et Al. 2021. CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS. 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , (Geneve, Switzerland), 112.
Anderson, E., Baquero Artıgao , F., Boucher, F. D., Campbell , J. D., Castellı Gattınara , G., Çetin, B. Ş., ... Dıez-Domıngo , J.(2021). CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS . 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) (pp.112). Geneve, Switzerland
Anderson, Evan Et Al. "CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS," 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID), Geneve, Switzerland, 2021
Anderson, Evan Et Al. "CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS." 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , Geneve, Switzerland, pp.112, 2021
Anderson, E. Et Al. (2021) . "CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS." 39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID) , Geneve, Switzerland, p.112.
@conferencepaper{conferencepaper, author={Evan Anderson Et Al. }, title={CHAD155-VECTORED RESPIRATORY SYNCYTIAL VIRUS (RSV) INVESTIGATIONAL VACCINE (CHAD155-RSV) IS IMMUNOGENIC WHEN ADMINISTERED AT DIFFERENT DOSE LEVELS IN INFANTS AGED 6–7 MONTHS}, congress name={39th Annual Meeting of the European Society of Paediatric Infectious Diseases (ESPID)}, city={Geneve}, country={Switzerland}, year={2021}, pages={112} }